Exhibit 23.4
2400 Ellis Road
Durham, North Carolina 27703
iqvia.com
AstraZeneca PLC
Legal & Secretary’s Department
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
England
AstraZeneca Finance LLC
1209 Orange Street
Wilmington, Delaware 19801
United States
For the attention of Adrian Kemp and David White
By email & by post
19 March 2024
Dear Ladies and Gentlemen
IQVIA DATA DISCLOSURE FOR ANNUAL REPORT AND FORM 20-F INFORMATION 2023
In connection with the filing of the accompanying Registration Statement on Form F-3 (the “Form F-3”) of AstraZeneca PLC (“AstraZeneca”) and AstraZeneca Finance LLC (“AstraZeneca Finance”), IQVIA Inc. (“IQVIA”) hereby authorizes AstraZeneca and AstraZeneca Finance to refer to IQVIA and certain pharmaceutical industry data derived by IQVIA, as identified on the pages included in Exhibit 15.3 to AstraZeneca’s Annual Report and Form 20-F Information for the fiscal year ended December 31, 2023 (the “Annual Report”), which Annual Report is incorporated by reference in the accompanying Form F-3 of AstraZeneca and AstraZeneca Finance, subject to the same acknowledgements and agreements as set forth in our letter from IQVIA to AstraZeneca PLC, dated 20 February 2024 and included in Exhibit 15.3 to the Annual Report.
Please indicate your agreement to the foregoing by signing in the space indicated below. Our authorization will not become effective until accepted and agreed by AstraZeneca and AstraZeneca Finance.
Very truly yours,
| /s/ Matthew R. Gilmartin | |
| Name: Matthew R. Gilmartin | |
| Title: SVP, Deputy General Counsel |
For and on behalf of IQVIA Inc.
ACCEPTED AND AGREED
This 19th day of March 2024
AstraZeneca PLC
| /s/ Adrian Kemp |
Name: Adrian Kemp
Title: Company Secretary
ACCEPTED AND AGREED
This 19th day of March 2024
AstraZeneca Finance LLC
| /s/ David White |
Name: David White
Title: Director